Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Dec;39(12):2625–2630. doi: 10.1128/aac.39.12.2625

Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease.

K A Nash 1, C B Inderlied 1
PMCID: PMC163001  PMID: 8592991

Abstract

Clarithromycin (CLM) and azithromycin (AZM) are important agents in the treatment of disseminated Mycobacterium avium complex disease; however, monotherapy with these macrolides often leads to clinically significant resistance. The underlying resistance mechanism was investigated by comparing 23S rRNA gene sequences in the domain V region of 10 CLM-susceptible strains included in this study. The only differences in the domain V sequences associated with CLM resistance were at position 2274 of the complete M. avium 23S rRNA gene (GenBank accession no. X74494). All the CLM-susceptible strains had an A residue at this site, whereas seven of the eight CLM-resistant strains had either a C, G, or T. Four of these seven CLM-resistant strains emerged during monotherapy with CLM and two emerged during AZM monotherapy, showing that resistance selected by either macrolide was associated with mutation of the 23S rRNA gene. Thermodynamic analysis of secondary rRNA structure suggests that the observed mutations cause an alteration in free energy associated with rRNA folding, which may result in a localized conformation change in assembled ribosomes. Such a shift may be important in the resistance of ribosomes to the effects of macrolides. This study therefore establishes a link between mutations within the 23S rRNA gene and clinically significant macrolide resistance in M. avium and also identifies a possible molecular mechanism of resistance at the level of the ribosome.

Full Text

The Full Text of this article is available as a PDF (302.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bercovier H., Kafri O., Sela S. Mycobacteria possess a surprisingly small number of ribosomal RNA genes in relation to the size of their genome. Biochem Biophys Res Commun. 1986 May 14;136(3):1136–1141. doi: 10.1016/0006-291x(86)90452-3. [DOI] [PubMed] [Google Scholar]
  2. Chaisson R. E., Benson C. A., Dube M. P., Heifets L. B., Korvick J. A., Elkin S., Smith T., Craft J. C., Sattler F. R. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. Ann Intern Med. 1994 Dec 15;121(12):905–911. doi: 10.7326/0003-4819-121-12-199412150-00001. [DOI] [PubMed] [Google Scholar]
  3. Coleman K., Athalye M., Clancey A., Davison M., Payne D. J., Perry C. R., Chopra I. Bacterial resistance mechanisms as therapeutic targets. J Antimicrob Chemother. 1994 Jun;33(6):1091–1116. doi: 10.1093/jac/33.6.1091. [DOI] [PubMed] [Google Scholar]
  4. Dautzenberg B., Truffot C., Legris S., Meyohas M. C., Berlie H. C., Mercat A., Chevret S., Grosset J. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):564–569. doi: 10.1164/ajrccm/144.3_Pt_1.564. [DOI] [PubMed] [Google Scholar]
  5. Douthwaite S., Aagaard C. Erythromycin binding is reduced in ribosomes with conformational alterations in the 23 S rRNA peptidyl transferase loop. J Mol Biol. 1993 Aug 5;232(3):725–731. doi: 10.1006/jmbi.1993.1426. [DOI] [PubMed] [Google Scholar]
  6. Ettayebi M., Prasad S. M., Morgan E. A. Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli. J Bacteriol. 1985 May;162(2):551–557. doi: 10.1128/jb.162.2.551-557.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fierro J. F., Hardisson C., Salas J. A. Involvement of cell impermeability in resistance to macrolides in some producer streptomycetes. J Antibiot (Tokyo) 1988 Jan;41(1):142–144. doi: 10.7164/antibiotics.41.142. [DOI] [PubMed] [Google Scholar]
  8. Heifets L., Mor N., Vanderkolk J. Mycobacterium avium strains resistant to clarithromycin and azithromycin. Antimicrob Agents Chemother. 1993 Nov;37(11):2364–2370. doi: 10.1128/aac.37.11.2364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Husson R. N., Ross L. A., Sandelli S., Inderlied C. B., Venzon D., Lewis L. L., Woods L., Conville P. S., Witebsky F. G., Pizzo P. A. Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndrome. J Pediatr. 1994 May;124(5 Pt 1):807–814. doi: 10.1016/s0022-3476(05)81380-0. [DOI] [PubMed] [Google Scholar]
  10. Jaeger J. A., Turner D. H., Zuker M. Improved predictions of secondary structures for RNA. Proc Natl Acad Sci U S A. 1989 Oct;86(20):7706–7710. doi: 10.1073/pnas.86.20.7706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jaeger J. A., Turner D. H., Zuker M. Predicting optimal and suboptimal secondary structure for RNA. Methods Enzymol. 1990;183:281–306. doi: 10.1016/0076-6879(90)83019-6. [DOI] [PubMed] [Google Scholar]
  12. Klemens S. P., DeStefano M. S., Cynamon M. H. Therapy of multidrug-resistant tuberculosis: lessons from studies with mice. Antimicrob Agents Chemother. 1993 Nov;37(11):2344–2347. doi: 10.1128/aac.37.11.2344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Masur H. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex. N Engl J Med. 1993 Sep 16;329(12):898–904. doi: 10.1056/NEJM199309163291228. [DOI] [PubMed] [Google Scholar]
  14. Meier A., Kirschner P., Springer B., Steingrube V. A., Brown B. A., Wallace R. J., Jr, Böttger E. C. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother. 1994 Feb;38(2):381–384. doi: 10.1128/aac.38.2.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sela S., Clark-Curtiss J. E., Bercovier H. Characterization and taxonomic implications of the rRNA genes of Mycobacterium leprae. J Bacteriol. 1989 Jan;171(1):70–73. doi: 10.1128/jb.171.1.70-73.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sigmund C. D., Ettayebi M., Borden A., Morgan E. A. Antibiotic resistance mutations in ribosomal RNA genes of Escherichia coli. Methods Enzymol. 1988;164:673–690. doi: 10.1016/s0076-6879(88)64077-8. [DOI] [PubMed] [Google Scholar]
  17. Suzuki Y., Yamada T. Study on rRNA genes in Mycobacterium smegmatis. Microbiol Immunol. 1988;32(12):1259–1262. doi: 10.1111/j.1348-0421.1988.tb01490.x. [DOI] [PubMed] [Google Scholar]
  18. Suzuki Y., Yoshinaga K., Ono Y., Nagata A., Yamada T. Organization of rRNA genes in Mycobacterium bovis BCG. J Bacteriol. 1987 Feb;169(2):839–843. doi: 10.1128/jb.169.2.839-843.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vannuffel P., Di Giambattista M., Morgan E. A., Cocito C. Identification of a single base change in ribosomal RNA leading to erythromycin resistance. J Biol Chem. 1992 Apr 25;267(12):8377–8382. [PubMed] [Google Scholar]
  20. Wallace R. J., Jr, Brown B. A., Griffith D. E., Girard W. M., Murphy D. T., Onyi G. O., Steingrube V. A., Mazurek G. H. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med. 1994 May;149(5):1335–1341. doi: 10.1164/ajrccm.149.5.8173775. [DOI] [PubMed] [Google Scholar]
  21. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother. 1995 Mar;39(3):577–585. doi: 10.1128/AAC.39.3.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Weiss I. K., Krogstad P. A., Botero C., Von Seidlein L., Nash K. Fatal Mycobacterium avium meningitis after mis-identification of M tuberculosis. Lancet. 1995 Apr 15;345(8955):991–992. doi: 10.1016/s0140-6736(95)90741-6. [DOI] [PubMed] [Google Scholar]
  23. Young L. S., Wiviott L., Wu M., Kolonoski P., Bolan R., Inderlied C. B. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet. 1991 Nov 2;338(8775):1107–1109. doi: 10.1016/0140-6736(91)91965-w. [DOI] [PubMed] [Google Scholar]
  24. Zuker M. On finding all suboptimal foldings of an RNA molecule. Science. 1989 Apr 7;244(4900):48–52. doi: 10.1126/science.2468181. [DOI] [PubMed] [Google Scholar]
  25. van der Giessen J. W., Haring R. M., van der Zeijst B. A. Comparison of the 23S ribosomal RNA genes and the spacer region between the 16S and 23S rRNA genes of the closely related Mycobacterium avium and Mycobacterium paratuberculosis and the fast-growing Mycobacterium phlei. Microbiology. 1994 May;140(Pt 5):1103–1108. doi: 10.1099/13500872-140-5-1103. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES